| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.3 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |